Need professional-grade analysis? Visit stockanalysis.com
$1.16B
456.67
4,731
N/A
Price Chart
Risk-Adjusted Performance
Aevis Victoria SA (AEVS) Price Performance
Aevis Victoria SA (AEVS) trades on SIX Swiss Exchange in CHF. The company is classified in the Healthcare sector under the Medical Care Facilities industry. The stock currently trades at CHF13.60, up 0.74% from the previous close.
Over the past year, AEVS has traded between a low of CHF11.50 and a high of CHF14.00. The stock has gained 12.4% over this period. It is currently 18.3% above its 52-week low.
Aevis Victoria SA has a market capitalization of $1.16B, with a price-to-earnings ratio of 456.67.
About Aevis Victoria SA
Aevis Victoria SA engages in the healthcare, hospitality, lifestyle, and infrastructure sectors in Switzerland. It operates through Hospitals, Hospitality, and Real Estate segments. The company operates private hospitals, hotels, radiology institute, pharmacy, urology center, health center, day clinics, and golf courses. It also provides health management programs, lifestyle coaching and anti-aging cosmeceuticals under the Nescens brand. In addition, the company offers ambulance, life sciences related services, medical home, physiotherapy, ophthalmology, sports medicine, medical radiation, stem cells, cosmetics, parking, cleaning services, sterilization, and IT related services. Further, it owns real estate properties in the healthcare and hospitality sectors. The company was founded in 2006 and is headquartered in Fribourg, Switzerland. Aevis Victoria SA operates as a subsidiary of M.R.S.I. Medical Research, Services and Investments S.A.
Company Info
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Exchange
- SIX Swiss Exchange
- Currency
- CHF
- Country
- Switzerland
Financial Metrics
- Revenue (TTM)
- $955.96M
- EBITDA
- $34.35M
- Profit Margin
- 0.22%
- EPS (TTM)
- 0.03
- Book Value
- 6.37
Technical Indicators
- 52 Week High
- CHF 14.00
- 52 Week Low
- CHF 11.50
- 50 Day MA
- CHF 13.55
- 200 Day MA
- CHF 13.34
- Beta
- -0.14
Valuation
- Trailing P/E
- 456.67
- Forward P/E
- N/A
- Price/Sales
- 1.21
- Price/Book
- 2.14
- Enterprise Value
- $1.32B